Next Article in Journal
1-[2,3-Bis(tetradecyloxy)propyl]-3-[2-(piperazin-1-yl)ethyl]urea
Previous Article in Journal
4-Chloro-2,3,5-trifluorobenzoic Acid
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one

1
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA
2
GlaxoSmithKline, Hvezdova 1734/2c, Prague 140 00, Czech Republic
3
Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
4
Department of Inorganic and Organic Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
5
Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
*
Author to whom correspondence should be addressed.
Molbank 2015, 2015(4), M872; https://doi.org/10.3390/M872
Submission received: 25 September 2015 / Revised: 27 October 2015 / Accepted: 2 November 2015 / Published: 4 November 2015

Abstract

:
3-Aminorhodanine reacts with aldehydes to form either 5-[(aryl)alkylidene]-substituted products or Schiff bases or derivatives substituted at both the 3-amino group and the 5-methylene group, depending on the reaction conditions. In this note, synthesis and characterization of 3-amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one is reported.

Graphical Abstract

1. Introduction

Rhodanine is one of the privileged scaffolds in drug discovery. Biological effects of various rhodanine derivatives have been reviewed by Tomasic and Masic [1,2]. Our research group has studied derivatives of rhodanine as potential antifungal and antimycobacterial agents [3,4,5,6]. Their influence on some photosynthetic processes was studied as well [7]. Some derivatives of 3-aminorhodanine were also prepared within these studies.
Initially, 3-aminorhodanine 1 was prepared for the first time by Andreasch [8]. With aldehydes it can form either 5-[(aryl)alkylidene]-substituted products 2 or Schiff bases 3 or derivatives substituted at both the 3-amino group and C(5) 4 (Figure 1), depending on the reaction conditions [9,10].
Stainier and Lapiere [9,10] used three different methods. When they performed condensation of equivalent amounts of 3-aminorhodanine 1 and an aldehyde in the presence of glacial acetic acid (method A) or in alcohol (method B), the derivative of the general formula 3 was obtained (Scheme 1).
However, condensation of 3-aminorhodanine with 4-dimethylaminobenzaldehyde in glacial acetic acid (method A) gave disubstituted product 4 (Scheme 2).
Condensation in alcoholic solution in the presence of NH4OH/NH4Cl (method C, so-called Girard’s method) always resulted in 5-[(aryl)alkylidene]-3-aminorhodanine 2 (Scheme 3).
Similar results were also reported by Petlichnaya and co-workers [11,12,13,14,15,16]. These authors found that 3-aminorhodanine exists in two tautomeric forms (Figure 2).
In an alcohol, 3-aminorhodanine 1 reacts in the “hydrazine” form I to give Schiff bases 3. In ammonia solution, 5-substituted derivatives 2 arise. Disubstituted derivatives 4 can be obtained by reacting 1 with an excess of aldehyde in glacial acetic acid. Nonetheless, in some cases, a two-step reaction must be used. It is possible to condense an aldehyde with a Schiff base 3 in ammonia solution or with a 5-substituted derivative 2 in an alcohol. Unsymmetrically substituted products can be prepared by these two-step reactions.
Several modified methods [17,18,19,20,21,22,23,24,25,26] for the condensation of 3-aminorhodanine with aldehydes have been reported. They clearly show that in basic medium the components react to yield 3-amino-5-[(aryl)alkylidene]-2-thioxo-1,3-thiazolidin-4-ones 2. Heating in alcohols gives 3-[(aryl)alkylidene]amino-2-thioxo-1,3-thiazolidin-4-one 3, while acidic catalysis results in 3 and/or disubstituted products 4.
In this note we wish to report on the synthesis (method C) and characterization of 3-amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one 5 (Figure 1).

2. Results and Discussion

Originally, 3-amino-5-(pyridin-3-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (CAS Registry Number 101714-49-2) and 3-amino-5-(pyridin-4-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (CAS Registry Number 101714-18-5) were reported by Lapiere in 1959 [10]. The compound 3-amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (5) has been registered with CAS Number 1082891-88-0. However, there are no references and no experimental data. Therefore, we tried to prepare and characterize the compound within our studies. Its structure (Figure S1) was corroborated by 1H-NMR spectrum (Figure S2), 13C-NMR spectrum (Figure S3) and HRMS (Figure S4), and the purity confirmed by elemental analysis.
Arylmethylidenerhodanines can form two isomers. According to references [27,28,29,30,31], syntheses of these compounds result in (Z)-izomers. The same has recently been proved for 3-aminorhodanine derivatives [25]. Configuration on the exocyclic double-bond can be determined on the basis of NMR spectra where 1H-NMR signals of the methine-group hydrogen for (Z)-isomers are more downfield compared to those expected for (E)-isomers. In our previous papers [5,7], the experimental signals of the –CH= group of various rhodanine derivatives were compared with the values reported previously in literature and the values predicted in silico. The (Z)–Isomers of arylmethylidenerhodanines exhibited experimental methine group shifts between 7.39–7.94 ppm, while (E)-isomers had methine group shifts in the range 6.78–7.01 ppm [5].
In the 1H-NMR spectrum of the 3-amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (5) reported in this note, only one set of signals was observed and the shift of –CH= is 7.85 ppm. The shifts predicted in silico (ChemDraw Professional 15.0, PerkinElmer Informatics, Waltham, MA, USA) were 7.63 ppm for (Z)-isomer and 7.01 ppm for (E)-isomer. Hence, it can be concluded that the prepared compound is (Z)-isomer.

3. Experimental Section

3.1. General Information

First, 3-aminorhodanine, 99% (Sigma-Aldrich, Steinheim, Germany) and pyridin-2-carbaldehyde, 99% (Sigma-Aldrich, Steinheim, Germany) were used as starting compounds. TLC was performed on TLC aluminium sheets, silica gel 60 F254 (Merck, Darmstadt, Germany). Mixtures light petroleum + ethyl acetate (4:6) and toluene + acetone (1:1) were used as mobile phases. Analytical sample was dried over anhydrous phosphorus pentoxide under reduced pressure at room temperature. Melting point was determined on a Boëtius apparatus PHMK 05 (VEB Kombinat Nagema, Radebeul, Germany) and is uncorrected. Elemental analysis was performed on an EA 1110 CHNS instrument (CE Instruments, Milano, Italy). 1H- and 13C-NMR spectra were recorded at ambient temperature on a Varian Mercury-Vx BB 300 spectrometer (Varian Corp., Palo Alto, CA, USA) operating at 300 MHz for 1H and 75 MHz for 13C. Chemical shifts were recorded as δ values in ppm, and were indirectly referenced to tetramethylsilane (TMS) via the solvent signal (2.49 for 1H, 39.7 for 13C in DMSO-d6). UHPLC system Acquity UPLC I-class (Waters, Millford, CT, USA) coupled to high resolution mass spectrometer (HRMS,) Synapt G2Si (Waters, Manchester, UK) based on Q-TOF were used for HRMS spectra measurement. Chromatography was performed using Acquity UPLC BEH C18 (2.1 mm × 50 mm, 1.7 µm) column using gradient elution with acetonitrile and 0.1% formic acid at flow rate 0.4 mL/min. Electrospray ionization was operated in positive mode. The ESI spectra were recorded in the range 50–1200 m/z using leucine-enkephalin as a lock mass reference and sodium formate for calibration.

3.2. Experimental Procedure for the Preparation of 3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (5)

Mixture of pyridin-2-carbaldehyde (1.0 g, 0.009 mol), 3-aminorhodanine (1.7 g, 0.009 mol) and concentrated ammonia (0.7 mL) in 15 mL of ethanol was heated to boiling. Ammonium chloride (0.7 g) dissolved in 2 mL of water heated to 80 °C was added to a clear solution, and the mixture refluxed for 2 h. After cooling, separated crystals were filtered off, washed with 50 mL of water and then 50 mL of ethanol diluted with water (1:1, v/v). The product was crystallized from acetone.
3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one (5). Yellow solid; yield 73%; m.p. 228–231 °C (decomp.) 1H-NMR (DMSO-d6, 300 MHz, δ ppm) 8.79–8.77 (m, 1H, Ar), 7.93–7.90 (m, 2H, Ar), 7.85 (s, 1H, CH), 7.45–7.42 (m, 1H, Ar), 5.89 (bs, 2H, NH2); 13C-NMR (DMSO-d6, 75 MHz, δ ppm) 194.4, 164.0, 151.5, 149.7, 137.9, 129.0, 128.5, 125.0, 124.4; EA for C9H7N3OS2 (237.30) calculated 45.55%C, 2.97%H, 17.71%N, 27.02%S, found 45.35%C, 3.23%H, 17.67%N, 27.44%S; HRMS (ESI): Calculated for C9H8N3OS2 [M + H]+ m/z 238.0109, found m/z 238.0109.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3Supplementary File 4

Acknowledgments

The study was supported by Ministry of Education, Youth and Sports of the Czech Republic, project SVV 260 183 and SVV 260 184.

Author Contributions

Petra Hirsova prepared the compound within her diploma work under supervision of Jan Dolezel. Marta Kucerova-Chlupacova checked the physicochemical data and wrote the experimental part; Jiri Kunes recorded and interpreted NMR data; Veronika Pilarova performed UHPLC, recorded and interpreted HRMS under supervision of Lucie Novakova. Veronika Opletalova proposed the subject, designed the study, and wrote the introduction and discussion. All the authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tomasic, T.; Masic, L.P. Rhodanine as a privileged scaffold in drug discovery. Curr. Med. Chem. 2009, 16, 1596–1629. [Google Scholar] [CrossRef] [PubMed]
  2. Tomasic, T.; Peterlin Masic, L. Rhodanine as a scaffold in drug discovery: A critical review of its biological activities and mechanisms of target modulation. Expert Opin. Drug Discov. 2012, 7, 549–560. [Google Scholar] [CrossRef] [PubMed]
  3. Dolezel, J.; Opletalova, V.; Vejsova, M.; Hirsova, P. Biological Evaluation of Thiazolidine Derivatives. Abstracts of the 5th International Postgraduate Research Symposium on Pharmaceutics (IPORSIP-2007), Istanbul, Turkey, 13–15 September 2007. Acta Pharm. Sci. 2007, 49 (Suppl.), 31. [Google Scholar]
  4. Petrik, P.; Kunes, J.; Vejsova, M.; Jampilek, J.; Spaningerova, E.; Kesetovicova, D.; Vlckova, M.; Majd, M.; Kalafutova, S.; Opletalova, V. Antifungal and antimycobacterial properties of 5-arylmethylidenerhodanines and their N3-substituted analogues. Abstracts of the 5th International Postgraduate Research Symposium on Pharmaceutics (IPORSIP-2007), Istanbul, Turkey, 13–15 September 2007. Acta Pharm. Sci. 2007, 49 (Suppl.), 77. [Google Scholar]
  5. Dolezel, J.; Hirsova, P.; Opletalova, V.; Dohnal, J.; Vejsova, M.; Kunes, J.; Jampilek, J. Rhodanineacetic acid derivatives as potential drugs: Preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids. Molecules 2009, 14, 4197–4212. [Google Scholar] [CrossRef] [PubMed]
  6. Opletalova, V.; Dolezel, J.; Buchta, V.; Vejsova, M.; Paterova, P. Antifungal effects of (5Z)-5-arylmethylidenerhodanines with a special view to members of Mucorales. Folia Pharm. Univ. Carol. 2014, 42, 7–13. [Google Scholar]
  7. Opletalova, V.; Dolezel, J.; Kralova, K.; Pesko, M.; Kunes, J.; Jampilek, J. Synthesis and characterization of (Z)-5-arylmethylidenerhodanines with photosynthesis-inhibiting properties. Molecules 2011, 16, 5207–5227. [Google Scholar] [CrossRef] [PubMed]
  8. Andreasch, R. Substituted rhodaninic acids and their aldehyde condensation products (VII). Monatsh. Chem. 1908, 29, 399–419. [Google Scholar] [CrossRef]
  9. Stainier, C.; Lapiere, C.L. Some derivatives of rhodanine with in vitro tuberculostatic action. Bull. Acad. R. Med. Belg. 1958, 23, 335–345. [Google Scholar] [PubMed]
  10. Lapiere, C.L. Aminorhodanine derivatives: Syntheses and tuberculostatic action. J. Pharm. Belg. 1959, 14, 126–140. [Google Scholar] [PubMed]
  11. Petlichnaya, L.I.; Turkevich, M.M. Some properties of 3-aminorhodanine. Dopov. Akad. Nauk Ukr. RSR 1965, 1601–1603, Chem. Abstr. 1966, 64, 59854. [Google Scholar]
  12. Petlichnaya, L.I. Double reactivity of 3-aminorhodanines. Khim. Geterotsikl. Soedin. 1967, 3, 649–652, Chem. Abstr. 1968, 68, 78182. [Google Scholar]
  13. Petlichnaya, L.I.; Turkevich, N.M. Synthesis of the new arylidene derivatives of 3-aminorhodanine. Khim. Geterotsikl. Soedin. 1968, 4, 73–75, Chem. Abstr. 1968, 69, 77148. [Google Scholar] [CrossRef]
  14. Turkevich, N.M.; Kontsevich, L.S.; Petlichnaya, L.I. 3-Aminorhodanine and its derivatives. Zb. Nauk Prats. L’vivsk. Med. Inst. 1963, 24, 22–28, Chem. Abstr. 1965, 62, 51596. [Google Scholar]
  15. Turkevich, M.M.; Tarasevicius, E. Synthesis of 5-arylidene derivatives of 3-(5-nitrofurfurylidene)aminorhodanine. Farm. Zh. (Kiev) 1968, 23, 44–47, Chem. Abstr. 1968, 69, 77154. [Google Scholar]
  16. Turkevich, N.M.; Petlichnaya, L.I. Ultraviolet absorption spectra of 3-aminorhodanine derivatives. Khim. Geterotsikl. Soedin. 1971, 7, 1182–1185, Chem. Abstr. 1972, 76, 58466. [Google Scholar]
  17. Sandstrom, J. Carboxydithiocarbohydrazides and N-aminorhodanines. Ark. Kemi 1955, 8, 487–521, Chem. Abstr. 1956, 50, 64634. [Google Scholar]
  18. Sugihara, A.; Ito, M. Nitrofuran derivatives. II. Condensation of nitrofuryl aldehydes with amines or 2-methyl-1,3,4-oxadiazoles. Yakugaku Zasshi 1965, 85, 424–429, Chem. Abstr. 1965, 63, 31685. [Google Scholar]
  19. Hanefeld, W.; Schlitzer, M. Regioselective condensations and N-acylations of 3-aminorhodanines. Arch. Pharm. 1993, 326, 887–891. [Google Scholar] [CrossRef]
  20. Stankovic, E.; Elecko, P.; Toma, S. Knoevenagel condensation of ferrocenecarbaldehyde with some methylene active reagents on inorganic supports. Chem. Pap. 1996, 50, 68–71. [Google Scholar]
  21. Krutosikova, A.; Lacova, M.; Dandarova, M.; Chovancova, J. Effect of microwave irradiation on reaction of furo[3,2-b]pyrrole- and furo[2,3-b]pyrrole-2-carbaldehydes with some active methylene compounds. ARKIVOC 2000, iii, 409–420. [Google Scholar]
  22. Afkhami, A.; Madrakian, T.; Ahmadi, R.; Bagheri, H.; Tabatabaee, M. Chemically modified alumina nanoparticles for selective solid phase extraction and preconcentration of trace amounts of Cd(II). Microchim. Acta 2011, 175, 69–77. [Google Scholar] [CrossRef]
  23. Tabatabaee, M.; Heravi, M.M.; Sharif, M.; Esfandiyari, F. Fast and efficient method for imination of N-aminorhodanine using inorganic solid support under microwave irradiation and classical heating. E-J. Chem. 2011, 8, 535–540. [Google Scholar] [CrossRef]
  24. Shivhare, S.; Mishra, R.; Gharia, A.; Gautam, M.D. Synthesis, characterization and antimicrobial studies of Cu(II), Co(II) and Ni(II) complexes with Schiff base derived from N-aminorhodanine and salicylaldehyde. Int. J. Pharm. Pharm. Sci. 2012, 4 (Suppl. 1), 394–397. [Google Scholar]
  25. Guiheneuf, S.; Paquin, L.; Carreaux, F.; Durieu, E.; Roisnel, T.; Meijer, L.; Bazureau, J.-P. New 5-ylidene rhodanine derivatives based on the dispacamide a model. Mol. Divers. 2014, 18, 375–388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Hoang, L.T.A.; Nguyen, T.C.; Tai, B.H.; Pham, H.Y.; Nguyen, X.N.; Thao, D.T.; Nguyen, H.N.; Minh, C.V.; Kiem, P.V.; Kim, Y.H. Synthesis of chromonylthiazolidines and their cytotoxicity to human cancer cell lines. Molecules 2015, 20, 1151–1160. [Google Scholar]
  27. Khodair, A.I. A convenient synthesis of 2-arylidene-5H-thiazolo[2,3-b]quinazoline-3,5[2H]-diones and their benzoquinazoline derivatives. J. Heterocycl. Chem. 2002, 39, 1153–1160. [Google Scholar] [CrossRef]
  28. Ohishi, Y.; Mukai, T.; Nagahara, M.; Yajima, M.; Kajikawa, N.; Miyahara, K.; Takano, T. Preparations of 5-alkylmethylidene-3-carboxymethylrhodanine derivatives and their aldose reductase inhibitory activity. Chem. Pharm. Bull. 1990, 38, 1911–1919. [Google Scholar] [CrossRef] [PubMed]
  29. Zidar, N.; Tomasic, T.; Sink, R.; Rupnik, V.; Kovac, A.; Turk, S.; Patin, D.; Blanot, D.; Contreras Martel, C.; Dessen, A.; et al. Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J. Med. Chem. 2010, 53, 6584–6594. [Google Scholar] [CrossRef] [PubMed]
  30. Tomasic, T.; Zidar, N.; Mueller-Premru, M.; Kikelj, D.; Masic, L.P. Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. Eur. J. Med. Chem. 2010, 45, 1667–1672. [Google Scholar] [CrossRef] [PubMed]
  31. Tomasic, T.; Kovac, A.; Simcic, M.; Blanot, D.; Golic Grdadolnik, S.; Gobec, S.; Kikelj, D.; Peterlin Masic, L. Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting d-Glu- and diphosphate-binding sites. Eur. J. Med. Chem. 2011, 46, 3964–3975. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Graphic representation of 3-aminorhodanine and its condensation products with aldehydes.
Figure 1. Graphic representation of 3-aminorhodanine and its condensation products with aldehydes.
Molbank 2015 m872 g001
Scheme 1. Condensation of 3-aminorhodanine with an aldehyde in glacial acetic acid (method A) or alcohol (method B).
Scheme 1. Condensation of 3-aminorhodanine with an aldehyde in glacial acetic acid (method A) or alcohol (method B).
Molbank 2015 m872 sch001
Scheme 2. Condensation of 3-aminohodanine with 4-dimethylaminobenzaldehyde in glacial acetic acid (method A).
Scheme 2. Condensation of 3-aminohodanine with 4-dimethylaminobenzaldehyde in glacial acetic acid (method A).
Molbank 2015 m872 sch002
Scheme 3. Condensation of 3-aminorhodanine with an aldehyde in alcoholic solution in the presence of NH4OH/NH4Cl (method C).
Scheme 3. Condensation of 3-aminorhodanine with an aldehyde in alcoholic solution in the presence of NH4OH/NH4Cl (method C).
Molbank 2015 m872 sch003
Figure 2. Tautomeric forms of 3-aminorhodanine.
Figure 2. Tautomeric forms of 3-aminorhodanine.
Molbank 2015 m872 g002

Share and Cite

MDPI and ACS Style

Hirsova, P.; Dolezel, J.; Kucerova-Chlupacova, M.; Kunes, J.; Pilarova, V.; Novakova, L.; Opletalova, V. (Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one. Molbank 2015, 2015, M872. https://doi.org/10.3390/M872

AMA Style

Hirsova P, Dolezel J, Kucerova-Chlupacova M, Kunes J, Pilarova V, Novakova L, Opletalova V. (Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one. Molbank. 2015; 2015(4):M872. https://doi.org/10.3390/M872

Chicago/Turabian Style

Hirsova, Petra, Jan Dolezel, Marta Kucerova-Chlupacova, Jiri Kunes, Veronika Pilarova, Lucie Novakova, and Veronika Opletalova. 2015. "(Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one" Molbank 2015, no. 4: M872. https://doi.org/10.3390/M872

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop